Article Information
History
- October 16, 2024.
Article Versions
- Version 1 (September 20, 2024 - 09:07).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Huimei Zhou1,2,3,#,
- Pengwu Zhang1,2,#,
- Chen Sun1,2,3,
- Zhenjian Ge1,2,4,
- Wenkang Chen1,2,4,
- Yingqi Li1,2,5,
- Shengjie Lin1,2,4,
- Yutong Wu1,2,4,
- Wuping Wang1,2,5,
- Siwei Chen1,2,5,
- Xutai Li1,2,3,
- Wei Li6 and
- Yongqing Lai1,2,*
- 1Department of Urology, Peking University Shenzhen Hospital, Shenzhen, 518036
- 2Institute of Urology, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, 518036
- 3The Fifth Clinical Medical College of Anhui Medical University, Hefei 230032
- 4Shantou University Medical College, Shantou, Guangdong 515041
- 5Shenzhen University Health Science Center, Shenzhen, China 518055
- 6Shenzhen KeRuiDa Health Technology Co., Ltd., Shenzhen, 518071
- ↵*Corresponding author: Yongqing Lai, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen 518036, E mail: yqlord{at}163.com.
↵# Contributed equally to this work.
Posted October 16, 2024.
Evaluation of the diagnostic value of YiDiXie™-SS, YiDiXie™-HS and YiDiXie™-D in gallbladder cancer
